Clinical Trial Update: Cabergoline As An Adjuvant To Clomiphene Citrate For Management Of Unexplained Infertility [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates that cabergoline is being studied as an adjuvant to clomiphene citrate for the management of unexplained infertility in Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unexplained Infertility

Drugs mentioned

• CABERGOLINE (CABERGOLINE)
• CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)

Snippet

Sponsor: Assiut University | Conditions: Infertility | Phase 2, Phase 3 | Status: UNKNOWN